Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.93 – $8.20
14% from low
Exchange
OTC Link
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $333.00B | $327.72B | $279.39B | $299.98B | $289.14B | $300.41B | $322.76B | $346.20B |
| Cost of revenue | $88.61B | $88.70B | $77.47B | $95.83B | $83.62B | $94.27B | $100.19B | $113.83B |
| Gross profit | $244.39B | $239.02B | $201.92B | $204.15B | $205.52B | $206.13B | $222.57B | $232.37B |
| Gross margin | 73.4% | 72.9% | 72.3% | 68.1% | 71.1% | 68.6% | 69.0% | 67.1% |
| R&D | $5.39B | $6.30B | $6.00B | $5.82B | $0 | $6.46B | $0 | $0 |
| Operating income | $52.41B | $40.23B | $13.29B | $25.24B | $22.12B | $16.27B | $17.36B | $19.42B |
| EBITDA | $62.90B | $50.58B | $30.19B | $36.47B | $39.37B | $26.86B | $29.55B | $32.55B |
| Net income | $37.00B | $26.68B | $11.99B | $17.79B | $18.77B | $11.66B | $7.51B | $15.85B |
| Net margin | 11.1% | 8.1% | 4.3% | 5.9% | 6.5% | 3.9% | 2.3% | 4.6% |
| EPS (diluted) | 129.74 | 93.55 | 42.02 | 62.37 | 65.81 | 40.88 | 26.32 | 54.90 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $343.1B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $355.5B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
KOSE HOLDINGS CO UNSP/ADR
No one on the platform currently holds KSRYY.
No tracked institution reports a position in KSRYY as of their last filing.
No one on the platform has traded KSRYY yet.
| $2.1B |
| — |
| ITOEFIto En, Ltd. | $18.82 | +0.00% | $2.2B | — |
| KBYPFKobayashi Pharmaceutical Co., Ltd. | $34.05 | +0.00% | $2.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.6× earnings vs its 0.4× historical median P/E.
Fair value ≈ $3.81 · price $6.25 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.